Back to Results
First PageMeta Content
Biology / Anandamide / Cannabinoid receptor antagonist / Cannabinoid receptor type 1 / 2-Arachidonoylglycerol / Cannabinoid / Tetrahydrocannabinol / Palmitoylethanolamide / Receptor antagonist / Cannabinoids / Chemistry / Biochemistry


P1: ARS February 3, 1998
Add to Reading List

Document Date: 2000-08-13 18:06:00


Open Document

File Size: 160,59 KB

Share Result on Facebook

City

Bethesda / Indianapolis / /

Company

Michelle Glass Laboratory / Eli Lilly Research Laboratories / /

Country

Guinea / India / /

Currency

pence / USD / /

/

Event

FDA Phase / /

Facility

National Institute of Mental Health / Michelle Glass Laboratory of Cellular / cAMP P1 / /

IndustryTerm

treatment of malaria / chemical analyses / toxic red oil / chemical structure / /

MedicalCondition

glaucoma / agonist dissociation / catalepsy / hypertension / malaria / pertussis / hypothermia / twitch / nausea / migraine / wasting disease / neuroblastoma cells / mouse neuroblastoma cells / pain / pains / AIDS / epilepsy / marijuana abuse / constipation / female disorders / /

MedicalTreatment

chemotherapy / /

Organization

Food and Drug Administration / National Institute of Mental Health / /

Person

Chen Nung / /

Position

Emperor / /

Product

L-CB1 / Marinol / MarinolĀ® / /

ProvinceOrState

Maryland / California / Arizona / Indiana / /

Region

Eastern Europe / /

Technology

Neuroscience / antibodies / gene expression / chemotherapy / /

SocialTag